0
Skip to Content
Arovella Therapeutics ASX: ALA
About
Mission Statement
Our Team
Governance
Technology
What are iNKT cells?
Solid Tumour Strategies
Publications & Conference Proceedings
Products
Pipeline
ALA-101: CAR19-iNKT
ALA-105: CLDN18.2-iNKT
Investors
Investor Centre
ASX Announcements
News & Presentations
Financial Reports
Analyst Coverage
ESG Reports
Contact
Arovella Therapeutics ASX: ALA
About
Mission Statement
Our Team
Governance
Technology
What are iNKT cells?
Solid Tumour Strategies
Publications & Conference Proceedings
Products
Pipeline
ALA-101: CAR19-iNKT
ALA-105: CLDN18.2-iNKT
Investors
Investor Centre
ASX Announcements
News & Presentations
Financial Reports
Analyst Coverage
ESG Reports
Contact
Folder: About
Back
Mission Statement
Our Team
Governance
Folder: Technology
Back
What are iNKT cells?
Solid Tumour Strategies
Publications & Conference Proceedings
Folder: Products
Back
Pipeline
ALA-101: CAR19-iNKT
ALA-105: CLDN18.2-iNKT
Folder: Investors
Back
Investor Centre
ASX Announcements
News & Presentations
Financial Reports
Analyst Coverage
ESG Reports
Contact

investor@arovella.com
+61.3.9863.6472

Subscribe to our Newsletters

Thank you for joining the database for Arovella Therapeutics - we will contact you with upcoming investor relation news.

Site by BDAC Media